| Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer Y Wu, NB Jennings, Y Sun, SK Dasari, E Bayraktar, S Corvigno, E Stur, ... Journal of cancer research and clinical oncology 148 (4), 803-821, 2022 | 8 | 2022 |
| Enhancing oral delivery of plant-derived vesicles for colitis Y Liu, AL Ahumada, E Bayraktar, P Schwartz, M Chowdhury, S Shi, ... Journal of Controlled Release 357, 472-483, 2023 | 4 | 2023 |
| Mechanisms and rational combinations with gp-2250, a novel oxathiazine derivative, in ovarian cancer MS Kim, D Glassman, AL Ahumada, E Bayraktar, NB Jennings, R Joseph, ... Cancer Res 83 (7_Supplement), 528-528, 2023 | 1 | 2023 |
| Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer Cancers 14 (15), 2022 | 1 | 2022 |
| Enhanced plant-derived vesicles for nucleotide delivery for cancer therapy S Corvigno, Y Liu, E Bayraktar, E Stur, NN Bayram, AL Ahumada, ... npj Precision Oncology 8 (1), 86, 2024 | | 2024 |
